title: X chromosome inactivation patterns in 45,X/46,XX mosaics.
abstract: To investigate X chromosome inactivation (XCI) patterns in 45,X/46.XX mosaics, genomic DNA was extracted from peripheral blood samples of 15 female subjects who showed different proportions of 45,X cell clones. XCI patterns were analyzed using two assays. The first assay was the BstXI restriction endonuclease detection of an X-linked phosphoglycerate kinase (PGK) gene polymorphism following digestion of the DNA with methylation-sensitive HpaII, or with methylation-insensitive AfaI as a control. The second assay was the detection of a CAG triplet repeat polymorphism in the X-linked androgen receptor (AR) gene after sodium bisulfite treatment. Of the 15 subjects, 11 were informative due to heterozygosity for at least one of the polymorphisms (6 were heterozygous for the PGK polymorphism and 9 were heterozygous for the AR polymorphism). Four of the 11 informative subjects (36%) showed extremely skewed XCI for at least one of the polymorphisms, which was a much higher incidence than previously reported for normal females. Moreover, 3 of these 4 women had proportions of 45,X cell clones greater than 20%. Although our results may be due to several possible cytogenetic or molecular mechanisms, the most likely explanation is that cases of 45,X/46,XX that contain relatively high levels of 45,X cell clones probably arose due to structural aberrations of the X chromosome undetectable by conventional karyotyping.
authors: Department of Obstetrics and Gynecology, Tohoku University, School of Medicine, Sendai, Japan. uehara@ob-gy.med.tohoku.ac.jp
authors: S
authors: S
authors: Uehara
authors: K
authors: K
authors: Sato
authors: M
authors: M
authors: Hashiyada
authors: Y
authors: Y
authors: Obara
authors: S
authors: S
authors: Matsuzaki
authors: M
authors: M
authors: Nata
authors: K
authors: K
authors: Okamura
mesh_terms: D001483:Base Sequence; D002869:Chromosome Aberrations; D017931:DNA Primers / Q000235:genetics; D015252:Deoxyribonucleases, Type II Site-Specific; D004303:Dosage Compensation, Genetic; D005260:Female; D006801:Humans; D009030:Mosaicism / Q000235:genetics*; D010735:Phosphoglycerate Kinase / Q000235:genetics; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011944:Receptors, Androgen / Q000235:genetics; D018911:Trinucleotide Repeats; D014424:Turner Syndrome / Q000235:genetics*
chemical_list: D017931:DNA Primers; D011944:Receptors, Androgen; D010735:Phosphoglycerate Kinase; C047564:CCANNNNNNTGG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific